Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

MAD: subcutaneous injection in the abdomen

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 14, 2026 · PHASE 1 TRIAL

Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Participants

ClinicalTrials.gov

This is a Phase 1 trial registration with no reported results; it describes a planned study of safety and tolerability in healthy and overweight/obese participants.

PreliminarySAD: subcutaneous injection in the abdomen NCT07765160 Healthy Participants

Reported

Planned enrollment96

PhasePHASE 1

Recruitment statusNOT_YET_RECRUITING

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support